Ph1b KRd + Daratumumab in NDMM (MMY1001) - Jakubowiak et al. #ASCO17 Abstract 8000 #mmsm ORR 100% (5% CR, 86% ≥ VGPR) in 21 response-evaluable pts
Ph1b KRd + Daratumumab in NDMM (MMY1001) - Jakubowiak et al. #ASCO17 Abstract 8000 #mmsm ORR 100% (5% CR, 86% ≥ VGPR) in 21 response-evaluable pts